NCT02994394View on ClinicalTrials.gov

A Study of OPC-41061 Orally Disintegrating (OD) Tablets Using 2 Different Formulations and 2 Dosing Regimens in Healthy Adult Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

January 6, 2017

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Healthy Adult Male
Interventions
DRUG

OPC-41061

Trial Locations (1)

Unknown

Kyusyu Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY